Background:
Repeat hepatectomy plays a key role in recurrent hepatic tumors. However, it is still unknown whether laparoscopic hepatectomy is suitable for recurrent liver cancers. The aim of this meta-analysis is to evaluate the efficacy and feasibility of laparoscopic repeat hepatectomy (LRH) compared with open repeat hepatectomy (ORH).
Methods:
Several databases, including Web of Science, PubMed, The Cochrane Library and Ovid, were retrieved from date of inception to 31st March 2018. All articles comparing LRH and ORH were identified. Tumor characteristics and perioperative outcomes including resection type, operation time, blood loss, transfusion, complications and hospital stay were evaluated. Data were extracted and calculated using random- or fixed-effect models.
Results:
A total of seven non-randomized observational clinical articles including 443 patients were analyzed. LRH was associated with significantly lower blood loss (WMD = -389.09, 95% CI -628.34 to -149.84, P = 0.001), transfusion (OR 0.16, 95% CI 0.03-0.74, P = 0.019) as well as limited hospital stay (WMD = -4.00, 95% CI -6.58 to -1.42, P = 0.002). No statistical difference was found in the field of tumor characteristics and other perioperative outcomes. In the sensitivity analysis of case-match studies, LRH was associated with significant limited hospital stay, but with significant longer operation time. There were 8 (1.8%, range 0-13.3%) cases of conversion in LRH group.
Conclusions:
Based on the results of these limited data, LRH is as feasible and efficient as ORH by expert surgeons in selected patients, whose cancer is resectable at the time of surgery and who have Child-Pugh A or B cirrhosis.
Citing Articles
Laparoscopic open radical resection in management of gallbladder carcinoma: A systematic review and meta-analysis.
He S, Yu T, Cao J, Zhou X, Chen Z, Jiang W
World J Clin Cases. 2023; 11(27):6455-6475.
PMID: 37900219
PMC: 10601008.
DOI: 10.12998/wjcc.v11.i27.6455.
A feasible and safe approach for repeat laparoscopic liver resection and patient selection based on standardized preoperative prediction of surgical difficulty.
Onda S, Haruki K, Furukawa K, Yasuda J, Okui N, Shirai Y
Langenbecks Arch Surg. 2023; 408(1):138.
PMID: 37014467
DOI: 10.1007/s00423-023-02880-x.
Surgical Outcomes of Laparoscopic versus Open Hepatectomy for Left Hepatocellular Carcinoma: Propensity Score Analyses Using Retrospective Japanese and Korean Individual Patient Data.
Kaibori M, Yoshii K, Umeda Y, Yagi T, Okabayashi T, Sui K
Liver Cancer. 2023; 12(1):32-43.
PMID: 36872920
PMC: 9982339.
DOI: 10.1159/000527294.
Outcomes and Patient Selection in Laparoscopic vs. Open Liver Resection for HCC and Colorectal Cancer Liver Metastasis.
Alvikas J, Lo W, Tohme S, Geller D
Cancers (Basel). 2023; 15(4).
PMID: 36831521
PMC: 9954110.
DOI: 10.3390/cancers15041179.
Predicting Complications following Surgical Resection of Hepatocellular Carcinoma Using Newly Developed Neo-Glasgow Prognostic Score with ALBI Grade: Comparison of Open and Laparoscopic Surgery Cases.
Kaibori M, Hiraoka A, Matsui K, Matsushima H, Kosaka H, Yamamoto H
Cancers (Basel). 2022; 14(6).
PMID: 35326554
PMC: 8946274.
DOI: 10.3390/cancers14061402.
Indications of Laparoscopic Repeat Liver Resection for Recurrent Hepatocellular Carcinoma.
Kinoshita M, Kanazawa A, Tanaka S, Takemura S, Amano R, Kimura K
Ann Gastroenterol Surg. 2022; 6(1):119-126.
PMID: 35106422
PMC: 8786700.
DOI: 10.1002/ags3.12493.
Multicenter Propensity Score-Based Study of Laparoscopic Repeat Liver Resection for Hepatocellular Carcinoma: A Subgroup Analysis of Cases with Tumors Far from Major Vessels.
Miyama A, Morise Z, Aldrighetti L, Belli G, Ratti F, Cheung T
Cancers (Basel). 2021; 13(13).
PMID: 34202373
PMC: 8268302.
DOI: 10.3390/cancers13133187.
Is minimally invasive surgery of lesions in the right superior segments of the liver justified? A multi-institutional study of 245 patients.
Gholami S, Judge S, Lee S, Mashayekhi K, Goh B, Chan C
J Surg Oncol. 2021; 122(7):1428-1434.
PMID: 33459363
PMC: 7978501.
DOI: 10.1002/jso.26154.
Laparoscopic repeat liver resection.
Morise Z
Ann Gastroenterol Surg. 2020; 4(5):485-489.
PMID: 33005842
PMC: 7511566.
DOI: 10.1002/ags3.12363.
Laparoscopic repeat liver resection for hepatic epithelioid hemangioendothelioma.
Terasaki F, Yamamoto Y, Sugiura T, Okamura Y, Ito T, Ashida R
Surg Case Rep. 2020; 6(1):254.
PMID: 33001327
PMC: 7530154.
DOI: 10.1186/s40792-020-01036-z.
Integrative analysis of dysregulated lncRNA-associated ceRNA network reveals potential lncRNA biomarkers for human hepatocellular carcinoma.
Li C, Zhang W, Yang H, Xiang J, Wang X, Wang J
PeerJ. 2020; 8:e8758.
PMID: 32201648
PMC: 7071826.
DOI: 10.7717/peerj.8758.
Local penetration of doxorubicin via intrahepatic implantation of PLGA based doxorubicin-loaded implants.
Gao L, Li Q, Zhang J, Huang Y, Deng L, Li C
Drug Deliv. 2019; 26(1):1049-1057.
PMID: 31691602
PMC: 6844384.
DOI: 10.1080/10717544.2019.1676842.
Outcomes of laparoscopic repeat liver resection for recurrent liver cancer: A system review and meta-analysis.
Peng Y, Liu F, Wei Y, Li B
Medicine (Baltimore). 2019; 98(41):e17533.
PMID: 31593128
PMC: 6799857.
DOI: 10.1097/MD.0000000000017533.